ethambutol has been researched along with triclosan in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aínsa, JA; Martín, C; Ramón-García, S; Thompson, CJ | 1 |
| Aminabhavi, TM; Dixit, SR; Joshi, SD; Kirankumar, MN; Lherbet, C; Narayan, R; Raju, KV; Yang, KS | 1 |
| Aminabhavi, TM; Dixit, SR; Joshi, SD; Kumar, D; Lherbet, C; More, UA; Tigadi, N; Yang, KS | 1 |
| Aminabhavi, TM; Dixit, SR; Joshi, SD; Kulkarni, VH; Lherbet, C; Nadagouda, MN | 1 |
| Doğan, H; Doğan, ŞD; Gündüz, MG; Krishna, VS; Lherbet, C; Şahin, O; Sarıpınar, E; Sriram, D | 1 |
| Doğan, H; Doğan, ŞD; Gündüz, MG; Krishna, VS; Lherbet, C; Sriram, D | 1 |
6 other study(ies) available for ethambutol and triclosan
| Article | Year |
|---|---|
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
Topics: Antitubercular Agents; Bacterial Proteins; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Clofazimine; Dithiothreitol; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Glutathione; Hydrogen Peroxide; Membrane Transport Proteins; Mutation; Mycobacterium tuberculosis; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Rifampin; Valinomycin | 2009 |
Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Enzyme Inhibitors; Escherichia coli; Humans; Isoxazoles; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Pyrroles; Staphylococcus aureus; Thiourea | 2016 |
Synthesis, characterization and antitubercular activities of novel pyrrolyl hydrazones and their Cu-complexes.
Topics: A549 Cells; Anti-Bacterial Agents; Antitubercular Agents; Cells; Coordination Complexes; Copper; Humans; Hydrazones; Ligands; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Quantitative Structure-Activity Relationship | 2016 |
Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; Binding Sites; Cell Line, Tumor; Chemistry Techniques, Synthetic; Computer Simulation; Drug Design; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Conformation; Pyrroles | 2017 |
Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Hydrazones; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; RAW 264.7 Cells; Structure-Activity Relationship; Thiadiazoles | 2020 |
Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; RAW 264.7 Cells; Structure-Activity Relationship; Thiourea | 2020 |